Evaluation of the renal function among sickle cell patients: a cross-sectional study

Published: 5 March 2025
Abstract Views: 41
PDF: 16
SUPPLEMENTARY MATERIAL: 5
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

This cross-sectional study aimed to explore the implications and effects of hematological and kidney function patterns in individuals with sickle cell disorder (SCD) residing in the Jazan Region of Saudi Arabia. In this study, a cohort of individuals (including sickle cell anemia patients, sickle cell trait carriers, and control subjects) at Abu-Arish General Hospital with a total of 172 sickle cell anemia patients, 70 patients with sickle cell traits, and 91 control subjects is evaluated. A 5 mL sample of venous blood was collected into ethylenediaminetetraacetic acid (EDTA) anticoagulated tubes and serum gel separator tubes for hematological tests and biochemical analysis, respectively. Hematological assays were performed in EDTA. Red blood cell (RBC) parameters were recorded. Renal function tests were conducted to determine serum analytes, including sodium, potassium, urea, and creatinine. The dimension auto-analyzer determined biochemical parameters. High-performance liquid chromatography was performed. The predominant variant observed in sickle cell anemia cases was sickle hemoglobin, accounting for 67.4% of the cases, whereas hemoglobin A1 constituted 22.4% of the cases. SCD patients exhibited elevated levels of white blood cells, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red cell distribution width, and platelets. Conversely, they displayed decreased levels of RBC, hemoglobin, hematocrit, and mean corpuscular volume. In addition, SCD patients demonstrated higher serum electrolyte levels compared to control subjects. Conversely, serum urea and creatinine levels were lower in SCD patients compared to control subjects. In conclusion, SCD patients commonly exhibit compromised kidney function. It is recommended that such patients be provided with comprehensive health education pertaining to their overall well-being and strategies for mitigating the risk of renal impairment.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Creary M, Williamson D, Kulkarni R. Sickle cell disease: current activities, public health implications, and future directions. J Women’s Health 2017;16:575-82. DOI: https://doi.org/10.1089/jwh.2007.CDC4
Okwi AL, Byarugaba W, Ndugwa CM, et al. An update on the prevalence of sickle cell trait in Eastern and Western Uganda. BMC Blood Disord 2010;10:5. DOI: https://doi.org/10.1186/1471-2326-10-5
Zaini R. Sickle-cell anemia and consanguinity among the Saudi Arabian population. Arch Med 2016;8:15.
Mandal AK, Mitra A, Das R. Sickle cell hemoglobin. Subcell Biochem 2020;94:297-322. DOI: https://doi.org/10.1007/978-3-030-41769-7_12
Steinberg MH. Fetal hemoglobin in sickle hemoglobinopathies: high HbF genotypes and phenotypes. J Clin Med 2020;9:3782. DOI: https://doi.org/10.3390/jcm9113782
Pagana KD, Pagana TJ, Pagana TN. Mosby’s diagnostic & laboratory test reference. 14th ed. St. Louis, MO, USA: Elsevier; 2018.
Hoffman R, Benz EJ, Silberstein LE, et al. Hematology: basic principles and practice. 2017. Available from: https://mayoclinic.elsevierpure.com/en/publications/hematology-basic-principles-and-practice.
Gibson JS, Rees DC. How benign is the sickle cell trait? EBioMedicine 2016;11:21-2. DOI: https://doi.org/10.1016/j.ebiom.2016.08.023
Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med 2011;31:289-93. DOI: https://doi.org/10.5144/0256-4947.2011.289
Ceglie G, Di Mauro M, Tarissi De Jacobis I, et al. Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study. Front Mol Biosci 2019;6:140. DOI: https://doi.org/10.3389/fmolb.2019.00140
Jit BP, Mohanty PK, Purohit P, et al. Association of fetal hemoglobin level with the frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients. Blood Cells Mol Dis 2019;75:30-4. DOI: https://doi.org/10.1016/j.bcmd.2018.12.003
Antwi-Boasiako C, Ekem I, Abdul-Rahman M, et al. Hematological parameters in Ghanaian sickle cell disease patients. J Blood Med 2018;9:203-9. DOI: https://doi.org/10.2147/JBM.S169872
Meshram AW, Bhatkulkar PA, Khare R, Pazare K. Hematological indices & electrolyte status in sickle cell disease at the rural hospital of Central Maharashtra. Int J Med Sci Public Health 2014;3:1410-2. DOI: https://doi.org/10.5455/ijmsph.2014.230820141
Omoti, CE. Hematological values in sickle cell anemia in steady state and during vaso-occlusive crisis in Benin City, Nigeria. Ann Afr Med 2005;4:62-7.
Ahmed AE, Ali YZ, Al-Suliman AM, et al. The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia. J Blood Med 2017;8:185-91. DOI: https://doi.org/10.2147/JBM.S148463
Mombo LE, Mabioko Mbembo G, Bisseye C, et al. Hematological values in steady state sickle cell anemia patients and matched hemoglobin AA controls in a rural area of Eastern Gabon. Nigerian Postgrad Med J 2019;26:13-7. DOI: https://doi.org/10.4103/npmj.npmj_182_18
Wazir ZU. Peripheral blood picture of sickle cell anemia. Gomal J Med Sci 2017;15(4):184.
Raffini LJ, Niebanck AE, Hrusovsky J, et al. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease. Pediatric Blood Cancer 2006;47:589-93. DOI: https://doi.org/10.1002/pbc.20579
Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia. J Pediatr Hematol Oncol 2005;27:145-7. DOI: https://doi.org/10.1097/01.mph.0000155871.26380.84
Meshram P, Pandey BD, Mankhand TR. Extraction of lithium from primary and secondary sources by pre-treatment, leaching and separation: a comprehensive review. Hydrometallurgy 2014;150:192-208. DOI: https://doi.org/10.1016/j.hydromet.2014.10.012
Antwi-Boasiako C, Kusi-Mensah YA, Hayfron-Benjamin C, et al. Serum potassium, sodium, and chloride levels in sickle cell disease patients and healthy controls: a case-control study at Korle-Bu Teaching Hospital, Accra. Biomarker Insights 2019;14:1177271919873889. DOI: https://doi.org/10.1177/1177271919873889
Pandey S, Sharma A, Dahia S, et al. Biochemical indicator of sickle cell disease: preliminary report from India. Ind J Clin Biochem 2012;27:191-5. DOI: https://doi.org/10.1007/s12291-011-0162-y
Abdulrahman IS. The kidney in sickle cell disease: pathophysiology and clinical review. Hong Kong J Nephrol 2004;6:2-13. DOI: https://doi.org/10.1016/S1561-5413(09)60120-4
Aloni MN, Ngiyulu RM, Gini-Ehungu JL, et al. Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings. PLoS One 2014;9:e96561. DOI: https://doi.org/10.1371/journal.pone.0096561
Al-Naama LM, Al-Sadoon TA, Al-Sadoon EA. Levels of uric acid, urea, and creatinine in Iraqi children with sickle cell disease. J Pak Med Assoc 2000;50:98-102.

How to Cite

Qadah, T., & Refaei, A. (2025). Evaluation of the renal function among sickle cell patients: a cross-sectional study. Italian Journal of Medicine, 19(1). https://doi.org/10.4081/itjm.2025.1868